BioCryst

+$0.30 (+1.86%) As of 4:14 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioCryst and other ETFs, options, and stocks.

About BCRX

BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the development and discovery of novel, oral, and small-molecule medicines. It focuses on the oral treatments for rare diseases in which significant unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease.

CEO
Jon P. Stonehouse
Employees
246
Headquarters
Durham, North Carolina
Founded
1986

BCRX Key Statistics

Market Cap
2.97B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.76M
High Today
$16.56
Low Today
$16.13
Open Price
$16.15
Volume
888.36K
52 Week High
$17.74
52 Week Low
$3.30

BCRX News

BenzingaJul 30

Analyzing BioCryst Pharmaceuticals's Unusual Options Activity - BioCryst Pharmaceuticals

Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved down to

BCRX Earnings

-$0.36
-$0.24
-$0.12
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure